Clovis Oncology Inc of Boulder, Colorado has signalled its confidence in an experimental drug for pancreatic cancer with the signing of a new development and commercialisation deal with the drug’s owner, Clavis Pharma ASA of Norway. ---Subscribe to MedNous to access this article--- Company News
